TELA Bio Income Statement (2018-2025) | TELA

Income Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 2.21M2.43M3.31M3.30M3.97M4.86M3.73M3.51M5.31M5.67M5.88M7.56M7.65M8.37M8.23M10.41M11.16M11.62M11.91M14.49M15.05M17.00M16.60M16.09M18.96M17.65M18.52M20.20M20.69M
Cost of Revenue 3.61M4.02M4.00M3.95M4.74M5.38M5.27M4.12M6.34M6.38M6.30M7.50M6.95M8.31M9.38M11.05M11.17M11.65M13.47M14.58M14.47M17.16M17.52M16.70M16.47M13.96M16.61M16.86M15.23M
Gross Profit 1.37M1.03M1.80M1.91M2.60M2.96M2.20M2.08M3.29M3.66M3.46M5.09M4.60M5.66M5.00M6.55M7.32M8.18M7.90M10.20M10.39M11.62M11.34M11.07M12.86M11.22M12.51M14.11M13.97M
Operating items
Amortization - Intangibles 0.08M0.09M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.54M0.10M0.10M0.10M0.10M0.10M0.12M0.10M0.10M0.10M0.12M0.10M0.10M0.10M
Research & Development 1.04M0.98M1.66M1.05M0.52M0.92M0.91M0.98M1.20M1.16M1.68M1.93M1.41M1.73M2.01M2.10M2.10M2.73M2.05M2.51M2.37M2.69M2.39M2.32M2.07M2.03M2.54M2.20M2.35M
Selling, General & Administrative 1.40M1.53M1.32M1.21M1.21M2.49M2.52M2.15M2.61M2.87M2.76M2.97M3.46M3.27M3.46M3.63M3.53M3.24M3.63M3.47M3.73M4.05M3.83M3.62M3.68M3.59M3.84M4.13M3.95M
Restructuring Costs 1.81M1.78M1.80M1.83M1.89M2.16M2.11M
Other Operating Expenses 2.16M4.00M3.95M4.74M5.38M5.27M4.12M6.34M6.38M6.30M7.50M6.95M8.31M9.38M11.05M11.17M11.65M13.47M14.58M14.47M17.16M7.58M14.72M14.70M13.12M
Operating Expenses 3.89M6.53M6.98M6.21M6.46M8.79M8.70M7.25M10.15M10.41M10.73M12.40M11.82M13.31M14.84M16.79M16.81M17.61M19.15M20.56M20.57M23.90M23.74M22.64M22.22M19.57M22.98M23.19M21.52M
Operating Income -2.52M-5.50M-5.18M-4.30M-3.86M-5.83M-6.50M-5.17M-6.86M-6.75M-7.27M-7.31M-7.22M-7.65M-9.84M-10.24M-9.49M-9.44M-11.25M-10.36M-10.18M-12.28M-4.83M-11.57M-9.37M-8.35M-10.47M-9.08M-7.55M
EBIT -2.52M-5.50M-5.18M-4.30M-3.86M-5.83M-6.50M-5.17M-6.86M-6.75M-7.27M-7.31M-7.22M-7.65M-9.84M-10.24M-9.49M-9.44M-11.25M-10.36M-10.18M-12.28M-4.83M-11.57M-9.37M-8.35M-10.47M-9.08M-7.55M
Non-operating items
Other Non Operating Income -0.28M-0.41M-0.79M0.03M0.06M0.18M0.16M-0.03M0.06M-0.14M0.02M-0.08M-0.13M-0.04M-0.11M-1.23M-0.20M0.47M0.87M0.56M0.73M0.50M0.30M0.34M0.28M0.48M0.38M0.15M
Non Operating Income -0.28M-1.89M-0.79M-0.96M-0.81M-0.71M-0.72M-0.92M-0.84M-1.04M-0.87M-0.94M-1.05M-0.96M-1.02M-2.50M-1.23M-0.54M-0.77M0.87M-0.78M4.61M-0.83M-1.03M-1.01M-1.00M-0.74M-0.81M-1.05M
Net income details
EBT -2.83M-6.26M-6.09M-5.21M-4.75M-6.71M-7.38M-6.05M-7.76M-7.65M-8.16M-8.18M-8.14M-8.58M-10.76M-11.17M-10.52M-10.61M-12.50M-11.66M-11.52M-13.62M-5.66M-12.60M-10.37M-9.35M-11.21M-9.89M-8.60M
Tax Provisions 0.05M0.03M
Profit After Tax -2.81M-7.39M-5.97M-5.26M-4.67M-6.53M-7.22M-6.08M-7.70M-7.79M-8.14M-8.26M-8.27M-8.62M-10.86M-12.74M-10.71M-9.98M-12.03M-10.79M-10.96M-12.89M-5.66M-12.60M-10.37M-9.21M-11.26M-9.92M-8.60M
Income from Continuing Operations -2.83M-6.26M-6.09M-5.21M-4.75M-6.71M-7.38M-6.05M-7.76M-7.65M-8.16M-8.18M-8.14M-8.58M-10.76M-11.17M-10.52M-10.61M-12.50M-11.66M-11.52M-13.62M-5.66M-12.60M-10.37M-9.35M-11.26M-9.92M-8.60M
Consolidated Net Income -2.83M-6.26M-6.09M-5.21M-4.75M-6.71M-7.38M-6.05M-7.76M-7.65M-8.16M-8.18M-8.14M-8.58M-10.76M-11.17M-10.52M-10.61M-12.50M-11.66M-11.52M-13.62M-5.66M-12.60M-10.37M-9.35M-11.26M-9.92M-8.60M
Income towards Parent Company -2.83M-6.26M-6.09M-5.21M-4.75M-6.71M-7.38M-6.05M-7.76M-7.65M-8.16M-8.18M-8.14M-8.58M-10.76M-11.17M-10.52M-10.61M-12.50M-11.66M-11.52M-13.62M-5.66M-12.60M-10.37M-9.35M-11.26M-9.92M-8.60M
Preferred Dividend Payments 1.87M1.98M2.02M2.76M2.06M0.94M
Net Income towards Common Stockholders -4.68M-9.37M-7.99M-8.02M-6.72M-7.47M-7.22M-6.08M-7.70M-7.79M-8.16M-8.18M-8.14M-8.58M-10.76M-11.17M-10.52M-10.61M-12.50M-11.66M-11.52M-13.62M-5.66M-12.60M-10.37M-9.35M-11.26M-9.92M-8.60M
Additional items
EPS (Basic) -15.84-31.71-27.00-27.06-22.5859.52-0.63-0.53-0.53-0.54-0.56-0.57-0.57-0.59-0.75-0.88-0.64-0.48-0.63-0.46-0.45-0.53-0.23-0.51-0.42-0.33-0.25-0.22-0.19
EPS (Weighted Average and Diluted) -4.23-0.60-0.56-0.57-0.57-0.59-0.75-0.88-0.64-0.48-0.63-0.46-0.45-0.53-0.23-0.51-0.42-0.33-0.25-0.22-0.19
Shares Outstanding (Weighted Average) 0.30M0.29M0.30M0.30M0.30M1.77M11.41M11.44M14.42M12.93M14.44M14.46M14.49M14.47M14.54M14.56M16.76M16.27M19.19M23.24M24.48M22.87M24.58M24.66M24.70M28.53M45.27M45.37M45.42M
Shares Outstanding (Diluted Average) 1.77M12.93M14.44M14.46M14.49M14.47M14.54M14.56M16.76M16.27M19.19M23.24M24.48M22.87M24.58M24.66M24.70M28.53M45.27M45.37M45.42M
EBITDA -2.81M-7.39M-5.97M-4.30M-4.67M-6.55M-7.19M-5.17M-6.86M-6.75M-7.27M-7.31M-7.22M-7.65M-9.84M-10.24M-9.49M-9.44M-12.06M-10.83M-10.91M-12.93M-5.66M-12.60M-10.32M-9.27M-11.26M-9.92M-8.61M
Interest Expenses 0.31M0.77M0.91M0.91M0.90M0.88M0.88M0.88M0.90M0.90M0.89M0.86M0.92M0.92M0.91M0.93M1.03M1.17M1.25M1.30M1.33M1.34M1.33M1.33M1.34M1.28M1.22M1.19M1.20M
Tax Rate -0.46%-0.33%